Min Han Selected Research

4N1K peptide

7/2022

Blocking CD47 with restructured peptide nanoparticles for motivating phagocytosis to inhibit tumor progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Han Research Topics

Disease

62	Neoplasms (Cancer) 07/2022 - 10/2006
13	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 09/2008
12	Breast Neoplasms (Breast Cancer) 06/2022 - 10/2012
10	Fibrosis (Cirrhosis) 10/2021 - 04/2011
8	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 07/2013
8	Tuberculosis (Tuberculoses) 06/2017 - 01/2010
7	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2012
7	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015 - 05/2006
6	Hypoxia (Hypoxemia) 07/2022 - 02/2008
6	IGA Glomerulonephritis (IGA Nephropathy) 02/2022 - 01/2015
5	Inflammation (Inflammations) 01/2021 - 06/2017
5	Infections 01/2020 - 05/2010
4	Carcinoma (Carcinomatosis) 07/2021 - 11/2008
4	Obesity 01/2021 - 01/2016
4	Lung Neoplasms (Lung Cancer) 10/2020 - 01/2012
3	Glioma (Gliomas) 03/2022 - 02/2013
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2012
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 08/2014
3	Hypercholesterolemia 01/2022 - 01/2013
3	Hypertension (High Blood Pressure) 01/2021 - 10/2013
3	Reperfusion Injury 01/2021 - 08/2014
3	Adenocarcinoma 01/2021 - 09/2008
3	Hemorrhage 01/2021 - 04/2006
3	Cognitive Dysfunction 01/2021 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 08/2015
3	Starvation 01/2017 - 11/2011
3	Colorectal Neoplasms (Colorectal Cancer) 08/2016 - 11/2004
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 01/2009
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2012
3	Pulmonary Tuberculosis 12/2014 - 06/2011
2	Poisoning 11/2022 - 01/2022
2	Brain Neoplasms (Brain Tumor) 03/2022 - 10/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Proteinuria 01/2022 - 09/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2018
2	Atrophy 10/2021 - 05/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2021 - 01/2019
2	Stroke (Strokes) 01/2021 - 01/2020
2	Adenocarcinoma of Lung 10/2020 - 09/2019
2	Pleural Tuberculosis 03/2020 - 06/2011
2	Extrapulmonary Tuberculosis 03/2020 - 06/2017
2	Ischemia 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 06/2022 - 10/2005
17	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 01/2011
16	Pharmaceutical PreparationsIBA 06/2022 - 09/2008
12	Peptides (Polypeptides)IBA 07/2022 - 05/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
8	Liposomes (Liposome)IBA 10/2020 - 09/2008
7	MicellesIBA 10/2020 - 05/2010
7	AutoantibodiesIBA 01/2016 - 07/2010
6	Messenger RNA (mRNA)IBA 05/2022 - 08/2009
5	EnzymesIBA 01/2022 - 02/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 02/2008
4	CreatinineIBA 01/2022 - 10/2016
4	PolymersIBA 01/2022 - 11/2011
4	CholesterolIBA 01/2022 - 01/2020
4	Biological ProductsIBA 01/2022 - 01/2012
4	Therapeutic UsesIBA 11/2021 - 01/2018
4	LipidsIBA 09/2021 - 08/2015
4	MicroRNAs (MicroRNA)IBA 11/2020 - 11/2011
4	NanodiamondsIBA 10/2020 - 10/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2011
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 11/2019
3	InterferonsIBA 01/2022 - 11/2014
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2012
3	HDL CholesterolIBA 01/2022 - 01/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 05/2021 - 01/2011
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 09/2008
3	LigandsIBA 01/2021 - 01/2012
3	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2020
3	CytokinesIBA 01/2021 - 11/2008
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2018
3	polyglycerolIBA 10/2020 - 10/2018
3	Folic Acid (Vitamin M)FDA LinkGeneric 08/2019 - 07/2013
3	AcidsIBA 01/2018 - 01/2012
3	Poloxamer (Poloxamer 407)IBA 11/2016 - 05/2010
3	polycaprolactoneIBA 10/2014 - 01/2011
2	BoronIBA 03/2022 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 10/2013
2	Uric Acid (Urate)IBA 01/2022 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 10/2013
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 03/2020
2	Long Noncoding RNAIBA 07/2021 - 01/2020
2	Immunoglobulin M (IgM)IBA 05/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 05/2021 - 01/2020
2	Complement C3 (C3 Complement)IBA 05/2021 - 01/2020
2	CateninsIBA 01/2021 - 02/2018
2	Neuroprotective AgentsIBA 01/2021 - 01/2020
2	celastrolIBA 10/2020 - 07/2009
2	Nucleic AcidsIBA 03/2020 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2019
2	ProdrugsIBA 01/2020 - 07/2015

Therapy/Procedure

22	Therapeutics 07/2022 - 05/2009
16	Drug Therapy (Chemotherapy) 01/2021 - 04/2009
3	Boron Neutron Capture Therapy 03/2022 - 01/2019
2	Immunotherapy 01/2022 - 11/2008